We expect a more supportive trading backdrop in Q3, helped by a favourable seasonal mix, encouraging...
The Weekly Edge Case turns the spotlight on a single company surfaced by Market Edge, taking the fra...
Redeye comments on Faron’s announcement that the first patient has been dosed in the investigator-in...
Redeye comments on SciBase’s rights issue outcome. The issue was subscribed to 73.
Kalqyl publicerar nu en sektorrapport om tio svenska mjukvarubolag med olika nischinriktningar och a...
Redeye comments on W5’s directed share issue of SEK165m which is carried out to strengthen its balan...
We leave our Base Case unchanged at SEK44 ahead of the Q3 report on 22 October, as the quarter shoul...
For Q3, we see strong PFPM/share growth, supported by buy-backs.
Redeye comments on this morning's press release, in which Cantargia reports preclinical data on nadu...
MustGrow's equity story remains centred on the commercial scaling of TerraSante and the longer-term ...
Vuxen inledde 2026/27 med en omsättningstillväxt på 27,0 % till 66,3 MSEK (52,2), bolagets högsta om...
KDventures' portfolio company AnaCardio has agreed to a EUR62.
Redeye briefly comments on yesterday’s announcement that OncoZenge has resolved on two directed shar...
Enviro has received court approval for a further three-month extension of its ongoing reconstruction...
* Sequential sales decline, but order activity has improved * We cut '26e-'28e EBIT by 11-8% on lowe...
Nokia has decided to discontinue its investment in the joint MoCA offering with InCoax and will remo...
Today Freemelt announced a new contract with Fusion for Energy (F4E) amounting to EUR 0.
Scanfil will arrange a CMD event on 29-30 September 2026 and M&A activity will become a bigger part ...
Redeye comments on Senzime’s business and financial update.
Redeye initiates coverage of Maven Wireless, the verified specification leader in tunnel DAS.
